دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Antiarrhythmic Drug Therapy: Where Do We Go From Here?.
Kowey, Peter R. MD; Naccarelli, Gerald V. MD
doi : 10.1161/CIRCULATIONAHA.123.066989
Volume 149(11) pgs. 801-896,e956-e959 March 12, 2024
Are Recommendations That Favor Other Agents Over Angiotensin-Converting Enzyme Inhibitors in Africans With Hypertension Justified?.
Peter, Jonathan G. MBChB, PhD; Ntusi, Ntobeko A.B. MBChB, PhD; Ntsekhe, Mpiko MBChB, PhD
Nonischemic or Dual Cardiomyopathy in Patients With Coronary Artery Disease.
Bawaskar, Parag MD, DM; Thomas, Nicholas BS; Ismail, Khaled MBBCh; Guo, Yugene BS; Chhikara, Sanya MBBS; Athwal, Pal Satyajit Singh MD; Ranum, Alison MD; Jadhav, Achal BA; Hooker Mendez, Abel MD; Nadkarni, Ishan; Frerichs, Dominic; Velangi, Pratik MD; Ergando, Tesfatsiyon MD; Akram, Hassan MD; Kanda, Adinan MD; Shenoy, Chetan MBBS, MS
Dual (Ischemic and Nonischemic) Cardiomyopathy: A Wolf in Sheep's Clothing.
Junca, Gladys MD; Delgado, Victoria MD; PhD
Effect of Dapagliflozin Versus Placebo on Symptoms and 6-Minute Walk Distance in Patients With Heart Failure: The DETERMINE Randomized Clinical Trials.
McMurray, John J.V. MD ,*; Docherty, Kieran F. MB ChB, PhD ,*; de Boer, Rudolf A. MD, PhD; Hammarstedt, Ann PhD; Kitzman, Dalane W. MD; Kosiborod, Mikhail N. MD; Maria Langkilde, Anna MD, PhD; Reicher, Barry MD; Senni, Michele MD; Shah, Sanjiv J. MD; Wilderang, Ulrica PhD; Verma, Subodh MD; Solomon, Scott D. MD ,*
Nature and Magnitude of the Benefits of Dapagliflozin and Empagliflozin for Heart Failure.
Cleland, John G.F. MD, PhD
Ganglioside GM3 Protects Against Abdominal Aortic Aneurysm by Suppressing Ferroptosis.
Zhang, Fangni PhD ,,*; Li, Kan PhD ,*; Zhang, Wenhui MS; Zhao, Ziyan PhD; Chang, Fangyuan MS; Du, Jie PhD; Zhang, Xu PhD; Bao, Kaiwen PhD; Zhang, Chunyong MS; Shi, Lei PhD; Liu, Zongwei PhD; Dai, Xiangchen MD; Chen, Chen MD, PhD; Wang, Dao Wen MD, PhD; Xian, Zhong PhD; Jiang, Hongfeng PhD; Ai, Ding PhD
Metabolic Communication by SGLT2 Inhibition.
Billing, Anja M. PhD; Kim, Young Chul PhD; Gullaksen, Soren MD; Schrage, Benedikt MD, PhD; Raabe, Janice PhD; Hutzfeldt, Arvid MSc; Demir, Fatih PhD; Kovalenko, Elina MSc; Lasse, Moritz PhD; Dugourd, Aurelien PhD; Fallegger, Robin MSc; Klampe, Birgit; Jaegers, Johannes PhD; Li, Qing PhD; Kravtsova, Olha PhD; Crespo-Masip, Maria PhD; Palermo, Amelia PhD; Fenton, Robert A. PhD; Hoxha, Elion MD; Blankenberg, Stefan MD; Kirchhof, Paulus MD; Huber, Tobias B. MD; Laugesen, Esben MD; Zeller, Tanja PhD; Chrysopoulou, Maria MSc; Saez-Rodriguez, Julio PhD; Magnussen, Christina; Eschenhagen, Thomas MD; Staruschenko, Alexander PhD; Siuzdak, Gary PhD; Poulsen, Per L. MD; Schwab, Clarissa PhD; Cuello, Friederike PhD; Vallon, Volker MD ,,*; Rinschen, Markus M. MD ,,,,*
End-Stage Heart Failure in Cardiac Sarcoidosis.
Velikanova, Diana MD; Poyhonen, Pauli MD, MSc; Lehtonen, Jukka MD; Simonen, Piia MD; Uusitalo, Valtteri MD; Vihinen, Tapani MD; Kaikkonen, Kari MD; Haataja, Petri MD; Kerola, Tuomas MD; Rissanen, Tuomas T. MD; Vepsalainen, Ville MD; Alatalo, Aleksi MD; Pietila-Effati, Paivi MD; Kupari, Markku MD
Abnormal Progenitor Cell Differentiation and Cardiomyocyte Proliferation in Hypoplastic Right Heart Syndrome.
Yu, Yang PhD; Wang, Cankun MS; Ye, Shiqiao PhD; Xu, Zhaohui PhD; Lin, Hui PhD; Texter, Karen MD; Shukla, Vasudha PhD; Ghadiali, Samir PhD; Ma, Qin PhD; Garg, Vidu MD; Zhao, Ming-Tao DVM, PhD
Letter by Heuts et al Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
Heuts, Samuel MD, PhD; Myers, Patrick O. MD; Siepe, Matthias MD
Letter by Rodriguez et al Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
Rodriguez, Alfredo E. MD, PhD; Fernandez-Pereira, Carlos MD, Ph.D; Mieres, Juan MD
Response by Zimmermann et al to Letter Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
Zimmermann, Frederik M. MD, PhD; Ding, Victoria Y. MS; Fearon, William F. MD
Correction to: Development and Validation of the American Heart Association's PREVENT Equations.
